The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis
Open accessAbstract
Background: The implications of different adiposity measures on cardiovascular disease etiology remain unclear. In this article, we quantify and contrast causal associations of central adiposity (waist-to-hip ratio adjusted for body mass index [WHRadjBMI]) and general adiposity (body mass index [BMI]) with cardiometabolic disease. Methods: Ninety-seven independent single-nucleotide polymorphisms for BMI and 49 single-nucleotide polymorphisms for WHRadjBMI were used to conduct Mendelian randomization analyses in 14 prospective studies supplemented with coronary heart disease (CHD) data from CARDIoGRAMplusC4D (Coronary Artery Disease Genome-wide Replication and Meta-analysis [CARDIoGRAM] plus The Coronary Artery Disease [C4D] Genetics; combined total 66 842 cases), stroke from METASTROKE (12 389 ischemic stroke cases), type 2 diabetes mellitus from DIAGRAM (Diabetes Genetics Replication and Meta-analysis; 34 840 cases), and lipids from GLGC (Global Lipids Genetic Consortium; 213 500 participants) consortia. Primary outcomes were CHD, type 2 diabetes mellitus, and major stroke subtypes; secondary analyses included 18 cardiometabolic traits. Results: Each one standard deviation (SD) higher WHRadjBMI (1 SD≈0.08 U) associated with a 48% excess risk of CHD (odds ratio [OR] for CHD, 1.48; 95% confidence interval [CI], 1.28–1.71), similar to findings for BMI (1 SD≈4.6 kg/m 2 ; OR for CHD, 1.36; 95% CI, 1.22–1.52). Only WHRadjBMI increased risk of ischemic stroke (OR, 1.32; 95% CI, 1.03–1.70). For type 2 diabetes mellitus, both measures had large effects: OR, 1.82 (95% CI, 1.38–2.42) and OR, 1.98 (95% CI, 1.41–2.78) per 1 SD higher WHRadjBMI and BMI, respectively. Both WHRadjBMI and BMI were associated with higher left ventricular hypertrophy, glycemic traits, interleukin 6, and circulating lipids. WHRadjBMI was also associated with higher carotid intima-media thickness (39%; 95% CI, 9%–77% per 1 SD). Conclusions: Both general and central adiposity have causal effects on CHD and type 2 diabetes mellitus. Central adiposity may have a stronger effect on stroke risk. Future estimates of the burden of adiposity on health should include measures of central and general adiposity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Obesity, characterized by excessive body fat, constitutes a major risk factor for the development of type 2 diabetes (T2D), dyslipidemia, cardiometabolic disease1, cancer2, and overall mortality3.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [1]
Experimental — accuracy not yet measuredIn the citing paper
“With increasing availability of large-scale phenotyping (and genotyping), MR is being widely applied to quantitative traits (e.g. markers or adiposity, such as body mass index 13-16 ; blood lipids such as HDL-cholesterol 17-19 ; inflammation-related proteins such as interleukin-6 receptor 20,21 12 ) with the aim of discovering modifiable risk factors for disease that are causal and amenable to the”
From Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development (2021) · cites this paper as [17]
In the citing paper
“HDL cholesterol 17,19 MRs do not provide evidence of causation, once unbalanced horizontal pleiotropy is taken into account”
From Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development (2021) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816
Bowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Genetic studies of body mass index yield new insights for obesity biology
Study, T. L. C., Locke, A. E., The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The, G. L. G. C., The, I. C. B. P., The MAGIC Investigators, The MuTHER Consortium, et al. (2015) · Nature · doi:10.1038/nature14177 · Cited by 4,534
Self-citationWiller (2013) · doi:10.1038/ng.2797 · Cited by 2,983
Self-citationYusuf, S., Hawken, S., Ôunpuu, S., Bautista, L., Franzosi, M. G., Commerford, P., Lang, C. C., Rumboldt, Z., Onen, C. L., Lisheng, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67663-5 · Cited by 2,903 · cited 1×
“We conducted 3 tests for the causal estimation of each adiposity measure on cardiometabolic outcomes: (1) inverse variance–weighted (IVW) method, (2) MR-Egger, and (3) weighted median.”
O'Donnell, M. J., Chin, S. L., Rangarajan, S., Xavier, D., Liu, L., Zhang, H., Rao-Melacini, P., Zhang, X., Pais, P., Agapay, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30506-2 · Cited by 2,296
Research works printed but not linked: 1
- R: A language and environment for statistical computing [computer program]. Vienna, Austria; 2013.
Cited by
Sorted by citations
Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
Davies, N. M., Holmes, M. V., & Davey Smith, G. (2018) · BMJ · doi:10.1136/bmj.k601 · Cited by 4,404
Self-citationMendelian randomization for cardiovascular diseases: Principles and applications
Larsson, S. C., Butterworth, A. S., & Burgess, S. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad736 · Cited by 735
“48 In a recent meta-analysis of MR studies, genetically predicted higher BMI was associated with an increased risk of all 14 studied CVDs. 46 56 Mendelian randomization studies have provided evidence that higher fasting insulin, fasting glucose, or glycated haemoglobin levels are causally…”
Mendelian randomization in cardiometabolic disease: challenges in evaluating causality
Holmes, M. V., Ala-Korpela, M., & Smith, G. D. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.78 · Cited by 679
Self-citationCauses, consequences, and treatment of metabolically unhealthy fat distribution
Stefan, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30110-8 · Cited by 566
The role of adipose tissue in cardiovascular health and disease
Oikonomou, E. K., & Antoniades, C. A. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0097-6 · Cited by 531
Metadata
- Authors
- Dale, C. E., Fatemifar, G., Palmer, T. M., White, J., Prieto-Merino, D., Zabaneh, D., Engmann, J. E. L., Shah, T., Wong, A., Warren, H. R., McLachlan, S., Trompet, S., Moldovan, M., Morris, R. W., Sofat, R., Kumari, M., Hyppönen, E., Jefferis, B. J., Gaunt, T. R., Ben-Shlomo, Y., Zhou, A., Gentry-Maharaj, A., Ryan, A., Mutsert, R. D., Noordam, R., Caulfield, M. J., Jukema, J. W., Worrall, B. B., Munroe, P. B., Menon, U., Power, C., Kuh, D., Lawlor, D. A., Humphries, S. E., Mook-Kanamori, D. O., Sattar, N., Kivimaki, M., Price, J. F., Davey Smith, G., Dudbridge, F., Hingorani, A. D., Holmes, M. V., & Casas, J. P.
- Affiliations
- Farr Institute (GB)
- From Farr Institute of Health Informatics Research, UCL Institute of Health Informatics, University College London, United Kingdom (C.E.D., G.F., D.P.-M., A.D.H., J.P.C.); Department of Mathematics and Statistics, Lancaster University, United Kingdom (T.M.P.); UCLGenetics Institute, University College London, United Kingdom (J.W.); Applied Statistical Methods in Medical Research Group, Universidad Catolica de San Antonio de Murcia, Spain (D.P.-M.); Social Genetic & Developmental Psychiatry,...
- ORCID
- Dale, Caroline E.
- Fatemifar, Ghazaleh
- Palmer, Tom M.
- White, Jon
- Zabaneh, Delilah
- Engmann, Jorgen E.L.
- Shah, Tina
- Wong, Andrew
- Warren, Helen R.
- McLachlan, Stela
- Trompet, Stella
- Moldovan, Max
- Morris, Richard W.
- Sofat, Reecha
- Hyppönen, Elina
- Jefferis, Barbara J.
- Gaunt, Tom R.
- Zhou, Ang
- Ryan, Andy
- Mutsert, Renée de
- Noordam, Raymond
- Caulfield, Mark J.
- Jukema, J. Wouter
- Worrall, Bradford B.
- Munroe, Patricia B.
- Menon, Usha
- Power, Chris
- Kuh, Diana
- Lawlor, Debbie A.
- Humphries, Steve E.
- Sattar, Naveed
- Dudbridge, Frank
- Hingorani, Aroon D.
- Holmes, Michael V.
- Casas, Juan P.
- Venue
- Circulation
- Published
- 2017-06-13
- Volume
- 135
- Issue
- 24
- Pages
- 2373-2388
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC5515354
- OpenAlex
- W2626288726
- Cited by
- 345
- References
- 45
- Citations by year
- 2026: 14 · 2025: 25 · 2024: 34 · 2023: 42 · 2022: 48 · 2021: 41 · 2020: 39 · 2019: 45 · 2018: 46 · 2017: 11
- FWCI
- 25.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (publishedVersion, other-oa)
- Bristol Research (University of Bristol) (publishedVersion, other-oa)
- Lancaster EPrints (Lancaster University) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Open Access at Essex (University of Essex) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Leicester Research Archive (University of Leicester) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- Explore Bristol Research (submittedVersion, other-oa)
- Funders
- Pfizer (RG/10/12/28456, K013351, ET2DS)
- National Institute for Health and Care Research (NF-SI-0515-10091, MC_UU_12013/1, NF-SI-0512-10113)
- British Heart Foundation (RG/08/008/25291, K013351, RG/10/12/28456, RG008/08, PG/13/66/30442, SP/13/6/30554)
- Imperial College London
- University College London
- European Commission (602757)
- Universiteit Leiden
- ZonMw (91614023)
- NordForsk (K013351)
- Leids Universitair Medisch Centrum
- Medical Research Council (MR/K013351/1, MR/K006584/1, RG/10/12/28456, K013351, MC_UU_12013, MR/N01104X/1, MC_UU_12013/1‐9, MCUU12013/1, MR/N01104X/2, ET2DS)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- adiposity, abdominal obesity, waist-to-hip ratio, body mass index, coronary artery disease, ischemic stroke, type 2 diabetes, cardiometabolic disease, left ventricular hypertrophy, carotid intima-media thickness, circulating lipids, interleukin-6, glycemic traits
- MeSH terms
- Coronary Disease, Diabetes Mellitus, Type 2, Humans, Longitudinal Studies, Prospective Studies, Stroke, Polymorphism, Single Nucleotide, Adiposity, Body Fat Distribution, Mendelian Randomization Analysis, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
